SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-24-000357
Filing Date
2024-03-06
Accepted
2024-03-06 06:00:40
Documents
6
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A lxrp_def14a.htm DEF 14A 446419
2 lxrp_def14aimg1.jpg GRAPHIC 10328
3 lxrp_def14aimg2.jpg GRAPHIC 177419
4 lxrp_def14aimg3.jpg GRAPHIC 128354
5 lxrp_def14aimg4.jpg GRAPHIC 175484
6 lxrp_def14aimg5.jpg GRAPHIC 186184
  Complete submission text file 0001640334-24-000357.txt   1381560
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-39874 | Film No.: 24724278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)